LifeBridge Health

LifeBridge Health Launches Mobile Van to Provide Vulnerable Communities Access to COVID-19 Testing, Senior and Pediatric Care

New Van Will Serve as Key Vehicle for Coordinated Effort for COVID-19 Vaccination Distribution Targeting Older Adults and Priority Groups

Newswise — Baltimore, MD- LifeBridge Health recently announced the launch of its “Care Happens Here” mobile unit, which will bring a wide range of healthcare testing and treatment services, including COVID-19 vaccinations, to vulnerable communities throughout central Maryland. The new mobile unit will offer a targeted “on the ground” approach to providing COVID-19 testing, medical care (including pediatrics, specialized senior care and post-acute care), as well as immunizations and referrals for further medical and social services. LifeBridge Health developed the Care Happens Here unit to assess and address social determinants of health and unmet needs in neighborhoods where residents often face multiple barriers to care, including lack of transportation, access to telemedicine resources, inability to afford care or prescriptions, and housing and food insecurity. The Care Happens Here unit debuts at the same time when LifeBridge Health joined with the Mayor of Baltimore, the City Health Commissioner and other local health partners in a coordinated initiative to use mobile units to bring COVID-19 vaccines to older adults and other priority groups who may have challenges in getting to vaccination clinics.

“At LifeBridge Health, our purpose statement is ‘Caring for Our Communities Together,’ and we are proud to join with the City of Baltimore and our fellow health partners in this initiative to bring COVID-19 vaccines into our communities. We are excited to be launching our new ‘Care Happens Here’ mobile unit at this same time, as this new mobile resource allows us to bring more of our healthcare services, including vaccinations, directly to the residents we serve,” says Rebecca Altman, LifeBridge Health vice president and chief integration officer.

At the Care Happen Here unit’s first COVID vaccination visit was February 19 at Harlem Gardens, a senior living facility in West Baltimore. The team vaccinated 50 residents that day and will return at later in March to administer the second dose of the Moderna vaccine.

“Our Care Happens Here unit is the latest example of our commitment to getting resources into the communities we serve in innovative and practical ways that meet the evolving needs of residents,” says Neil Meltzer, president and CEO of LifeBridge Health. “While our team at LifeBridge Health has always been proactive in this regard, the COVID-19 pandemic has caused us to dig deeper to find novel ways to Care Bravely and make a positive impact on the health of our communities.”

Unit Serves as ‘Doctor’s Office on Wheels’ The customized van includes a mobile treatment room equipped with clinical supplies and equipment found in a typical doctor’s office, including:

  • A full patient exam table that can accommodate adult and pediatric patients. Refrigeration and freezer space for storage of vaccines, including the Moderna COVID-19 vaccine.
  • Technology and connectivity required to record data and support telehealth visits if patients require care from a provider in LifeBridge Health’s Virtual Hospital.
  • Infant scale as well as a regular scale for weighing adults and children.
  • Privacy curtains and window tinting to protect patient privacy.
  • Eye-catching custom graphics that signify to area residents that Care Happens Here and resources are available.

Care Happens Here unit visits are scheduled in advance with patients and are targeted using a data-driven approach to get resources to those individuals at greatest risk based on numerous factors, including age, chronic diseases, population density, and social determinants of health.  The units are staffed by a combination of physicians, nurses, community health workers, and other team members, including advanced practice providers such as nurse practitioners and physician assistants. The composition of the staff on board is customized each day depending on the types of patients they are serving.

Pilot Program Demonstrated Need and Results

The Care Happens Here Unit was inspired and informed by a pilot program LifeBridge Health implemented following the onset of the COVID pandemic using repurposed patient transport vans.

Those two initial units made more than 315 patient visits during the six-week pilot program in this past summer. The visits were targeted using a data-driven approach to get resources to those individuals at greatest risk for negative outcomes for COVID-19. Of the 315 patients seen, more than 80% had abnormal blood pressure, more than 50% had three or more underlying chronic medical conditions, and more than 30% had not seen a primary care physician in over a year.

“The results of our pilot program spoke to a growing need in our communities that has to be addressed,” says Sharon McClernan, vice president of clinical integration at LifeBridge Health. “Beyond the impacts of COVID-19 within these vulnerable populations, we saw alarming trends of people deferring care for other medical issues, and it was clear we needed to take a more personal approach to serving people’s holistic needs in the home. The Care Happens Here unit is a perfect extension of our ongoing population health efforts throughout central Maryland.”

Video/broll for media:


Video – About the Care Happens Here van:


About LifeBridge Health LifeBridge Health is one of the largest, most comprehensive providers of health services in Maryland. LifeBridge Health includes Sinai Hospital of BaltimoreNorthwest HospitalCarroll HospitalLevindale Hebrew Geriatric Center and HospitalGrace Medical Center and related subsidiaries and affiliates. For more information, visit                                                                      # # #

Filters close

Showing results

110 of 5872
Released: 24-Jun-2021 4:55 PM EDT
Virus that causes COVID-19 can find alternate route to infect cells
Washington University in St. Louis

The virus that causes COVID-19 normally gets inside cells by attaching to a protein called ACE2. Researchers at Washington University School of Medicine in St. Louis have found that a single mutation confers the ability to enter cells through another route, which may threaten the effectiveness of COVID-19 vaccines and therapeutics designed to block the standard route of entry.

Newswise: Is it a Virus or Bacteria? New Tech Rapidly Tests for COVID-19 and More
Released: 24-Jun-2021 3:05 PM EDT
Is it a Virus or Bacteria? New Tech Rapidly Tests for COVID-19 and More
Homeland Security's Science And Technology Directorate

S&T is preparing for future outbreaks/pandemics by investing in a new tech that can quickly discriminate between bacterial and viral infections so that the U.S. can triage patients and plan a response without delay.

Released: 24-Jun-2021 12:30 PM EDT
A tecnologia de IA e ECG pode descartar rapidamente a infecção por COVID-19, concluiu o estudo da Mayo Clinic
Mayo Clinic

A inteligência artificial (IA) pode oferecer uma maneira de determinar com precisão se uma pessoa não está infectada com a COVID-19. Um estudo retrospectivo internacional descobriu que a infecção pelo SARS-CoV-2, o vírus que causa a COVID-19, cria mudanças elétricas sutis no coração. Um eletrocardiograma (ECG) habilitado com IA pode detectar essas alterações e, potencialmente, ser usado como um teste de triagem rápido e confiável para descartar a infecção por COVID-19.

Released: 24-Jun-2021 12:10 PM EDT
妙佑医疗国际(Mayo Clinic)的研究发现,AI赋能的心电图技术有可能迅速排除COVID-19感染
Mayo Clinic

AI (人工智能)有可能提供准确判断一个人未感染COVID-19(2019冠状病毒病)的方法。一项国际回顾性研究发现,如果感染了导致COVID-19的SARS-CoV-2病毒,患者的心脏会产生微妙的电学变化。AI赋能的心电图(EKG)可以检测到这些变化,并有望被用于进行快速、可靠的COVID-19筛查检测,以排除COVID-19感染。

Newswise: 200421_Felgner_3205_sz-2-768x496.jpg
Released: 24-Jun-2021 11:50 AM EDT
UCI Professor Wins Spain’s Prestigious Princess of Asturias Award for Scientific Research
University of California, Irvine

Irvine, Calif., June 24, 2021 — Philip Felgner, Ph.D., professor in residence of physiology & biophysics at the University of California, Irvine, is one of seven scholars worldwide to win Spain’s prestigious Princess of Asturias Award for Technical and Scientific Research in recognition of their contributions to designing COVID-19 vaccines.

Released: 24-Jun-2021 11:00 AM EDT
New protein engineering method could accelerate the discovery of COVID-19 therapeutics
University of Michigan

Discovering and engineering nanobodies with properties suitable for treating human diseases ranging from cancer to COVID-19 is a time-consuming, laborious process.

Newswise: Decoding humans’ survival from coronaviruses
Released: 24-Jun-2021 11:00 AM EDT
Decoding humans’ survival from coronaviruses
University of Adelaide

An international team of researchers co-led by the University of Adelaide and the University of Arizona has analysed the genomes of more than 2,500 modern humans from 26 worldwide populations, to better understand how humans have adapted to historical coronavirus outbreaks.

access_time Embargo lifts in 2 days
Embargo will expire: 29-Jun-2021 4:00 PM EDT Released to reporters: 24-Jun-2021 10:35 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 29-Jun-2021 4:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: COVIDLockdownSimulations.jpg
Released: 24-Jun-2021 10:00 AM EDT
Pandemic Air Quality Affected By Weather, Not Just Lockdowns
Washington University in St. Louis

Using a diverse set of tools, the lab of Randall Martin shows how the pandemic did – or didn’t – affect levels of particulate matter during COVID lockdowns.

Released: 24-Jun-2021 6:05 AM EDT
Longest known SARS-CoV-2 infection of nearly 300 days successfully treated with new therapy
University of Bristol

An immunocompromised individual with the longest known PCR confirmed case of SARS-CoV-2 infection, lasting more than 290 days, has been successfully treated with two investigational monoclonal antibodies (laboratory engineered antibodies). Clinicians and researchers from the University of Bristol and North Bristol NHS Trust (NBT) worked closely to assess and treat the infection and want to highlight the urgent need for improved access to treatments for such people with persistent SARS-CoV-2 infection.

Showing results

110 of 5872